在神经退行性疾病中,免疫机制和共享的免疫点
1Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. hweiner@bwh.harvard.edu.
Nature reviews. Neurology
|December 16, 2024
概括
免疫系统显著影响神经退行性疾病,如阿尔茨海默氏症和帕金森病. 针对大脑免疫细胞 (微细胞) 和外围细胞,为多种神经疾病提供了有希望的,共享的治疗策略.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病 神经退行性疾病
- 治疗策略 治疗策略
背景情况:
- 免疫系统是神经退行性疾病的组成部分,作为主要驱动器或放大器.
- 关键的免疫细胞包括中枢神经系统中的微质细胞和T细胞和单细胞等外围细胞.
- 现有的研究表明,在各种神经退行性疾病中,共享免疫机制.
研究的目的:
- 审查微质细胞,单细胞和T细胞在多发性硬化症,阿尔茨海默病,肌缩侧面硬化症和帕金森病的发病过程中的作用.
- 探索这些免疫细胞作为神经退行性疾病的常见治疗点的潜力.
- 突出微生物组作为一个新兴的间接免疫调节目标.
主要方法:
- 关于神经退行性疾病中神经炎症的当前文献的全面审查.
- 分析特定免疫细胞类型 (微细胞,单细胞,T细胞) 对疾病发病的贡献.
- 检查新兴的免疫治疗策略及其跨疾病适用性.
主要成果:
- 微质是大脑中的核心免疫参与者,对神经退行产生重大影响.
- 周围免疫细胞,包括调节性T细胞和单细胞,也会影响中枢神经系统的病理.
- 在多种神经退行性疾病中存在共享的免疫标和途径,这表明交叉治疗应用的潜力.
结论:
- 针对特定的免疫细胞,如微质细胞,单细胞和T细胞,为各种神经退行性疾病提供了统一的治疗途径.
- 针对一种疾病开发的免疫治疗方法可能适应其他疾病,从而优化治疗的发展.
- 调节免疫系统,包括通过微生物群,对于未来的神经退行性疾病疗法至关重要.
相关概念视频
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
The Blood-brain Barrier
46.7K
Overview
46.7K
Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476


